BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Katsiki N, Giannoukas AD, Athyros VG, Mikhailidis DP. Lipid-lowering treatment in peripheral artery disease. Current Opinion in Pharmacology 2018;39:19-26. [DOI: 10.1016/j.coph.2018.01.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Oikonomou E, Tousoulis D. Editorial overview: Cardiovascular and renal: Novel therapies in peripheral artery disease. Curr Opin Pharmacol 2018;39:iv-vi. [PMID: 29941177 DOI: 10.1016/j.coph.2018.06.001] [Reference Citation Analysis]
2 Katsiki N, Dimitriadis G, Hahalis G, Papanas N, Tentolouris N, Triposkiadis F, Tsimihodimos V, Tsioufis C, Mikhailidis DP, Mantzoros C. Sodium-glucose co-transporter-2 inhibitors (SGLT2i) use and risk of amputation: an expert panel overview of the evidence. Metabolism. 2019;96:92-100. [PMID: 30980838 DOI: 10.1016/j.metabol.2019.04.008] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 8.7] [Reference Citation Analysis]
3 Elseweidy MM, Elswefy SE, Younis NN, Tarek S. The modulation of PCSK-9 and GAGs by 10-dehydrogingerdione and pentoxifylline in hyperlipidemic rabbits. Nat Prod Res 2020;34:2372-7. [PMID: 30580599 DOI: 10.1080/14786419.2018.1536134] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Pasquin S, Laplante V, Kouadri S, Milasan A, Mayer G, Tormo AJ, Savin V, Sharma M, Martel C, Gauchat J. Cardiotrophin-like Cytokine Increases Macrophage–Foam Cell Transition. J I 2018;201:2462-71. [DOI: 10.4049/jimmunol.1800733] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
5 Veljkovic N, Zaric B, Djuric I, Obradovic M, Sudar-Milovanovic E, Radak D, Isenovic ER. Genetic Markers for Coronary Artery Disease. Medicina (Kaunas) 2018;54:E36. [PMID: 30344267 DOI: 10.3390/medicina54030036] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
6 Katsiki N, Mikhailidis DP. Lipids: a personal view of the past decade. Hormones 2018;17:461-78. [DOI: 10.1007/s42000-018-0058-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
7 Golledge J, Ward NC, Watts GF. Lipid management in people with peripheral artery disease. Curr Opin Lipidol 2019;30:470-6. [PMID: 31577608 DOI: 10.1097/MOL.0000000000000638] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
8 Katsiki N, Tousoulis D. Diabetes mellitus and comorbidities: A bad romance. Hellenic Journal of Cardiology 2020;61:23-5. [DOI: 10.1016/j.hjc.2020.02.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Paraskevas KI, Liapis CD, Veith FJ. Outcomes in patients with familial hypercholesterolaemia undergoing vascular surgical procedures. Curr Med Res Opin 2020;36:1253-4. [PMID: 32468867 DOI: 10.1080/03007995.2020.1776236] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Horiuchi Y, Lai SJ, Kameda T, Tozuka M, Ohkawa R. Novel cholesterol efflux assay using immobilized liposome-bound gel beads: Confirmation and improvement for application in clinical laboratory. Ann Clin Biochem 2021;:45632211054406. [PMID: 34719976 DOI: 10.1177/00045632211054406] [Reference Citation Analysis]